Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 2/2017

05.11.2016 | Assisted Reproduction Technologies

Female infertility, infertility-associated diagnoses, and comorbidities: a review

verfasst von: Brent Hanson, Erica Johnstone, Jessie Dorais, Bob Silver, C. Matthew Peterson, James Hotaling

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study is to evaluate existing literature for possible associations between female infertility, infertility-associated diagnoses, and the following areas of disease: psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction.

Methods

The design of the study is a literature review. The patients were women included in 26 selected studies due to a diagnosis of infertility or a reproductive disorder associated with infertility. This study has no interventions, and the main outcome measure is the association between female infertility or a related diagnosis and psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction.

Results

Female infertility and related reproductive disorders may have ramifications for women beyond reproductive health. An analysis of publications shows that women with infertility had higher rates of psychiatric disorders and endometrial cancer than the general population [110]. Data is conflicting about whether infertile women are at increased risk for breast cancer and ovarian cancer [7, 8, 1020]. A generalized diagnosis of infertility was not clearly associated with an increased risk of cardiovascular disease or metabolic dysfunction, but women with infertility related to polycystic ovarian syndrome (PCOS) do appear more likely to develop cardiovascular disease and metabolic disorders such as diabetes than the general population [16, 2126].

Conclusions

Female infertility and associated diagnoses have overall health implications. Beyond treatment of patients’ immediate reproductive needs, healthcare professionals must be aware of the broader health impact of specific causes of infertility in order to provide accurate counseling regarding long-term risk.
Literatur
1.
Zurück zum Zitat Valoriani VFL, Lari D, Miccinesi G, Vaiani S, Vanni C, Coccia ME, et al. Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study. Europ J Obstet Gynecol Reprod Biol. 2016;197:179–85.CrossRef Valoriani VFL, Lari D, Miccinesi G, Vaiani S, Vanni C, Coccia ME, et al. Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study. Europ J Obstet Gynecol Reprod Biol. 2016;197:179–85.CrossRef
2.
Zurück zum Zitat Veltman-Verhulst S. Emotional distress is a common risk in women with polycystic ovarian syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638–51.CrossRefPubMed Veltman-Verhulst S. Emotional distress is a common risk in women with polycystic ovarian syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638–51.CrossRefPubMed
3.
Zurück zum Zitat Gokhan A. Level of anxiety, depression, self esteem, social anxiety, and quality of life among women with polycystic ovarian syndrome. Sci World J. 2013;2013:7. Gokhan A. Level of anxiety, depression, self esteem, social anxiety, and quality of life among women with polycystic ovarian syndrome. Sci World J. 2013;2013:7.
4.
Zurück zum Zitat Jedel E. Anxiety and depression symptoms in women with polycystic ovarian syndrome compared with controls matched for body mass index. Hum Reprod. 2009;25(2):450–6.CrossRefPubMed Jedel E. Anxiety and depression symptoms in women with polycystic ovarian syndrome compared with controls matched for body mass index. Hum Reprod. 2009;25(2):450–6.CrossRefPubMed
5.
Zurück zum Zitat Baldur-Felskov P. disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod. 2013;28(3):683–90.CrossRefPubMed Baldur-Felskov P. disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod. 2013;28(3):683–90.CrossRefPubMed
6.
Zurück zum Zitat Hart RDD. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911–9.CrossRefPubMed Hart RDD. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911–9.CrossRefPubMed
7.
Zurück zum Zitat Venn A. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet. 1999;354(9190):1586–90.CrossRefPubMed Venn A. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet. 1999;354(9190):1586–90.CrossRefPubMed
8.
Zurück zum Zitat Barry J. Risk of endometrial, ovarian, and breast CA in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748–58.CrossRefPubMedPubMedCentral Barry J. Risk of endometrial, ovarian, and breast CA in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748–58.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Brinton L. Fertility drugs and endometrial cancer risk: results from an extended follow up from a large infertility cohort. Hum Reprod. 2013;28(10):2813–21.CrossRefPubMedPubMedCentral Brinton L. Fertility drugs and endometrial cancer risk: results from an extended follow up from a large infertility cohort. Hum Reprod. 2013;28(10):2813–21.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Venn A. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995;346(8981):995–1000.CrossRefPubMed Venn A. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995;346(8981):995–1000.CrossRefPubMed
11.
Zurück zum Zitat Lundberg F. Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study. Breast Cancer Res. 2016;18(1):36.CrossRefPubMedPubMedCentral Lundberg F. Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study. Breast Cancer Res. 2016;18(1):36.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kim J. Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population based case-control study. Cancer Causes Control. 2016;27(3):403–14.CrossRefPubMed Kim J. Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population based case-control study. Cancer Causes Control. 2016;27(3):403–14.CrossRefPubMed
13.
Zurück zum Zitat Gabriele V. Infertility and breast cancer: is there a link? Updated review of the literature and meta-analysis. Gynecol Obstet Fertil. 2016;44(2):113–20.CrossRefPubMed Gabriele V. Infertility and breast cancer: is there a link? Updated review of the literature and meta-analysis. Gynecol Obstet Fertil. 2016;44(2):113–20.CrossRefPubMed
14.
Zurück zum Zitat Reigstad M. Risk of breast cancer following fertility treatment—a registry based cohort study of parous women in Norway. Int J Cancer. 2015;136(5):1140–8.CrossRefPubMed Reigstad M. Risk of breast cancer following fertility treatment—a registry based cohort study of parous women in Norway. Int J Cancer. 2015;136(5):1140–8.CrossRefPubMed
18.
Zurück zum Zitat Cirillo P. Irregular menses predicts ovarian cancer. Int J Cancer. 2016. Cirillo P. Irregular menses predicts ovarian cancer. Int J Cancer. 2016.
19.
Zurück zum Zitat Bjornholt S. Risk for borderline ovarian tumors after fertility drugs: results of a population based cohort study. Hum Reprod. 2015;30(1):222–31.CrossRefPubMed Bjornholt S. Risk for borderline ovarian tumors after fertility drugs: results of a population based cohort study. Hum Reprod. 2015;30(1):222–31.CrossRefPubMed
20.
Zurück zum Zitat Rizzuto I. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013:8. Rizzuto I. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013:8.
21.
Zurück zum Zitat Parikh N. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational Study. Circulation. 2016. Parikh N. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational Study. Circulation. 2016.
22.
Zurück zum Zitat Ghaffarzad A. Correlation of serum lipoprotein ratios with insulin resistance in infertile women with PCOS: a case control study. Int J Fertil Steril. 2016;10(1):29–35.PubMedPubMedCentral Ghaffarzad A. Correlation of serum lipoprotein ratios with insulin resistance in infertile women with PCOS: a case control study. Int J Fertil Steril. 2016;10(1):29–35.PubMedPubMedCentral
23.
Zurück zum Zitat El-Hayek. Polycystic ovarian syndrome: an updated overview. Front Physiol. 2016. 7(124). El-Hayek. Polycystic ovarian syndrome: an updated overview. Front Physiol. 2016. 7(124).
24.
Zurück zum Zitat Polat S. Thyroid disorders in young females with PCOS and correlation of thyroid volume with certain hormonal parameters. J Reprod Med. 2016;61(1–2):27–32.PubMed Polat S. Thyroid disorders in young females with PCOS and correlation of thyroid volume with certain hormonal parameters. J Reprod Med. 2016;61(1–2):27–32.PubMed
25.
Zurück zum Zitat Zahiri Z. Metabolic syndrome in patients with polycystic ovarian syndrome in Iran. Int J Fertil Steril. 2016;9(4):490–6.PubMed Zahiri Z. Metabolic syndrome in patients with polycystic ovarian syndrome in Iran. Int J Fertil Steril. 2016;9(4):490–6.PubMed
26.
Zurück zum Zitat Ramezani-Binabaj M. Are women with polycystic ovarian syndrome at high risk of non-alcoholic fatty liver disease; a meta-analysis. Hepat Mon. 2014. 14(11): p. Ramezani-Binabaj M. Are women with polycystic ovarian syndrome at high risk of non-alcoholic fatty liver disease; a meta-analysis. Hepat Mon. 2014. 14(11): p.
27.
Zurück zum Zitat Aghajanova L. Obstetrics and gynecology residency and fertility needs: national survey results. Reprod Sci. 2016. Aghajanova L. Obstetrics and gynecology residency and fertility needs: national survey results. Reprod Sci. 2016.
28.
Zurück zum Zitat Prevention C.f.D.C.a. Assisted reproductive technology success rates: national summary and fertility clinic reports. US Department of Health and Human Services. 2010. Prevention C.f.D.C.a. Assisted reproductive technology success rates: national summary and fertility clinic reports. US Department of Health and Human Services. 2010.
29.
Zurück zum Zitat SART, National Summary Report. 2014, Society for Assisted Reproductive Technology: SART Website (www.sart.org). SART, National Summary Report. 2014, Society for Assisted Reproductive Technology: SART Website (www.​sart.​org).
31.
Zurück zum Zitat Tarin J. Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases. Reprod Biol Endocrinol. 2015. 13(31). Tarin J. Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases. Reprod Biol Endocrinol. 2015. 13(31).
32.
Zurück zum Zitat Escobedo L. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol. 1991;77(1):124–8.PubMed Escobedo L. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol. 1991;77(1):124–8.PubMed
33.
Zurück zum Zitat Modan B. Cancer incidence in a cohort of infertile women. Am J Epidemiol. 1998;147(11):1038–42.CrossRefPubMed Modan B. Cancer incidence in a cohort of infertile women. Am J Epidemiol. 1998;147(11):1038–42.CrossRefPubMed
34.
Zurück zum Zitat Althius M. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol. 2005;161(7):607–15.CrossRef Althius M. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol. 2005;161(7):607–15.CrossRef
35.
Zurück zum Zitat Silva-Idos S. Ovulation-stimulation drugs and cancer risks: a long-term follow up of a British cohort. Br J Cancer. 2009;100(11):1824–31.CrossRefPubMed Silva-Idos S. Ovulation-stimulation drugs and cancer risks: a long-term follow up of a British cohort. Br J Cancer. 2009;100(11):1824–31.CrossRefPubMed
36.
Zurück zum Zitat Lerner-Geva L. Are infertility treatments a potential risk factor for cancer development? perspective of 30 years of follow-up. Gynecol Endocrinol. 2012;28(10):809–14.CrossRefPubMed Lerner-Geva L. Are infertility treatments a potential risk factor for cancer development? perspective of 30 years of follow-up. Gynecol Endocrinol. 2012;28(10):809–14.CrossRefPubMed
37.
Zurück zum Zitat Oktay K. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian CA risks. J Clin Oncol. 2010;28(2):240–4.CrossRefPubMed Oktay K. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian CA risks. J Clin Oncol. 2010;28(2):240–4.CrossRefPubMed
38.
41.
Zurück zum Zitat Hu M. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring. Proc Natl Acad Sci U S A. 2015;112(46):14348–535.CrossRefPubMedPubMedCentral Hu M. Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring. Proc Natl Acad Sci U S A. 2015;112(46):14348–535.CrossRefPubMedPubMedCentral
Metadaten
Titel
Female infertility, infertility-associated diagnoses, and comorbidities: a review
verfasst von
Brent Hanson
Erica Johnstone
Jessie Dorais
Bob Silver
C. Matthew Peterson
James Hotaling
Publikationsdatum
05.11.2016
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 2/2017
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-016-0836-8

Weitere Artikel der Ausgabe 2/2017

Journal of Assisted Reproduction and Genetics 2/2017 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.